| TRANSMEDICS GROUP |
| USA |
| Gesundheit |
| US89377M1099 / A2PH5P |
| 8T8 (Frankfurt) / TMDX (NASDAQ) |
| FRA:8T8, ETR:8T8, 8T8:GR, NASDAQ:TMDX |
| - |
| https://www.transmedics.c.. |
|
TransMedics Group, Inc. is a commercial-stage medical technology company focused on organ transplant therapy. The company develops and commercializes the Organ Care System (OCS), a platform designed to preserve, monitor, and assess donor organs outsi..
>Volltext.. |
| 2057.32 Mio. EUR |
| 2401.65 Mio. EUR |
| 594.89 Mio. EUR |
| 105.04 Mio. EUR |
| 135 Mio. EUR |
| 3.94 EUR |
| 772.21 Mio. EUR |
| 420.65 Mio. EUR |
| 129.86 Mio. EUR |
| 4.81 |
| 29.78% |
| 118.35% |
| - |
| - |
| - |
| - |
| TRANSMEDICS |
| 04.11.26 |
|